Maternal and Neonatal Outcome of the Pregnant With COVID-19 in Istanbul,
Turkey: A Single-Center, Descriptive Study
Abstract
Objective To determine maternal and neonatal outcomes in pregnant women
with COVID-19 Design Retrospective, descriptive study Setting A
single-center managing pregnant women with COVID-19 Population or Sample
Third-trimester pregnant women with a diagnosis of COVID-19 Methods A
retrospective, single-center, descriptive study Main Outcome Measures
The maternal and neonatal results of COVID-19 pregnant women were
evaluated by looking at the following parameters: the concentrations of
D-dimer, complete blood count, ferritin, C-reactive protein,
lymphocytes, alanine aminotransferase (ALT) and aspartate
aminotransferase (AST), neonatal umbilical blood gas analyzes, real-time
RT-PCR tests, lung CT imaging, admission to (neonatal) intensive care
unit. Results In the third trimester, 40 pregnant women with COVID-19
were included. The most common complaint was cough (50%). The most
common symptom that accompanied cough was fever and shortness of breath.
Thirty-four patients delivered by cesarean and 6 patients delivered
vaginally. Two patients were taken to the intensive care unit because of
respiratory distress. There were no maternal and fetal deaths. The
patients were hospitalized for an average of 5 days. One patient was
followed up without treatment, while all other patients were given
hydroxychloroquine. In addition, azithromycin, oseltamivir, or
lopinavir/ritonavir were added to some patients in addition to
hydroxychloroquine. Conclusions The clinical features of pregnant women
with COVID-19 are comparable compared to non-pregnant adults. Long-term
results and comparative studies are needed in this regard.